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ABSTRACT
Five Sib antitoxin RNAs, members of a family of
cis-encoded small regulatory RNAs (sRNAs) in
Escherichia coli, repress their target mRNAs,
which encode Ibs toxins. This target repression
occurs only between cognate sRNA–mRNA pairs
with an exception of ibsA. We performed
co-transformation assays to assess the ability of
SibC derivatives to repress ibsC expression,
thereby revealing the regions of SibC that are essen-
tial for ibsC mRNA recognition. SibC has two target
recognition domains, TRD1 and TRD2, which
function independently. The target site for TRD1 is
located within the ORF of ibsC, whereas the target
site for TRD2 is located in the translational initiation
region. The TRD1 sequence is sufficient to repress
ibsC expression. In contrast, TRD2 requires a
specific structure in addition to the recognition
sequence. An in vitro structural probing analysis
showed that the initial interactions at these two rec-
ognition sites allowed base-pairing to progress into
the flanking sequences. Displacement of the TRD1
and TRD2 domains of SibC by the corresponding
domains of SibD changed the target specificity of
SibC from ibsC to ibsD, suggesting that these two
elements modulate the cognate target recognition
of each Sib RNA by discriminating among
non-cognate ibs mRNAs.
INTRODUCTION
Over the past decade, researchers have paid increasing
attention to the functions of small regulatory RNAs
(sRNAs) as gene-expression regulators in bacteria (1–5).
Bacterial sRNAs are typically 50–400nt in length
and found in intergenic regions. Approximately 100
sRNAs have been found in Escherichia coli, and recent
systematic searches have indicated that hundreds of
sRNAs exist (6–12). Functional studies of sRNAs have
shown that most are encoded in trans and that they
regulate translation and mRNA stability by base-pairing
with their target mRNAs, usually with the help of the Hfq
protein (13–17). Alternatively, a small number of sRNAs
[e.g. CsrB (18,19) and 6S RNA (20)] regulate gene expres-
sion by directly binding to their target proteins. In
addition, another class of sRNAs encoded on the
strands opposite their targets has been found in various
bacterial genomes. Unlike trans-encoded sRNAs, these
cis-encoded sRNAs share extensive complementary se-
quences with their targets through overlapping transcribed
regions. A variety of regulation mechanisms of cis-
encoded antisense sRNAs have been studied and most
of these sRNAs have been well characterized in mobile
genetic elements such as plasmids, transposons and
phages (21,22). These sRNAs include: RNAI–RNAII of
ColE1 and CopA–CopT of R1, which regulate plasmid
copy number; RNA-IN/RNA-OUT-controlling IS10
transposition; and the Hok/Sok toxin/antitoxin pair of
plasmid R1. A key component of antisense regulation is
the recognition of target RNAs by cis-encoded sRNAs.
Initial base-pairing is required to form a transient inter-
mediate known as a ‘kissing complex’, which can then
form a complete duplex (23,24).
Recent studies have also discovered chromosomal cis-
encoded antisense sRNAs and identiﬁed their biological
functions (25–31). With a few exceptions (26–28), most
chromosomal cis-encoded RNAs inhibit the synthesis of
toxins whose overexpression leads to cell death or growth
stasis (25,29–31). Chromosomal antitoxin RNAs are
encoded on the opposite strand of overlapping or
adjacent toxin genes and promote the translational repres-
sion or degradation of toxin mRNAs (32,33). At least six
toxin–antitoxin pairs have been identiﬁed in the E. coli
K-12 genome (21,32,33). Interestingly, some of these
pairs are present in multiple copies. The E. coli K-12
chromosome contains ﬁve genes that are homologous to
the plasmid-derived Hok/Sok genes (34). In addition, four
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sequence variations (25,31). On the other hand, three
toxin–antitoxin pairs (i.e. ShoB/OhsC, SymE/SymR and
TisB/IstR-1; note that OhsC and IstR-1 are not cis-
encoded) are present in single copies in the E. coli K-12
genome (25,30,35).
The chromosomal toxin/antitoxin systems except
for ShoB/OhsC and TisB/IstR-1 are regulated by
cis-encoded sRNA interactions, but the detailed mechan-
ism remains unclear (32,33). The simplest mechanism
would involve the binding of antitoxin RNA to the trans-
lation initiation region (TIR) of toxin mRNA, thereby
inhibiting the translation or degrading mRNA. SymR
represses the synthesis of SymE by base-pairing to the
TIR of symE mRNA, leading to symE mRNA degrad-
ation (30). Alternatively, the ldrD translational reporter
fusion may be repressed by the portion of the RdlD
sequence that does not overlap with the TIR of ldrD
mRNA (31).
Five Sib antitoxin RNAs (i.e. SibA, SibB, SibC,
SibD and SibE) are transcribed from the repetitive
Sib sequences diﬀerently located in the E. coli
K-12 genome (25). These ﬁve antitoxin RNAs are
approximately 140nt in length and share high sequence
homology. The opposite strand of each sib gene encodes
a toxic Ibs protein that consists of 18–19 highly hydropho-
bic amino-acid residues. Increased expression of Ibs
proteins aﬀects the cell envelope and is lethal to the cell.
The toxicity of Ibs proteins can be repressed by the con-
stitutive expression of Sib antitoxin RNAs (25).
Interactions between Sib-ibs mRNAs are unique
among cis-encoding sRNA regulatory systems in that
the sRNA sequence spans the entire functional mRNA
sequence, including the TIR and ORF. Therefore,
Sib RNAs have the potential for highly extensive
base-pairing with their targets. However, the extent of
the RNA–RNA interaction required for regulation,
and how this interaction occurs, remain unclear.
Furthermore, except for the SibA/ibsA pair, Sib RNAs
seem to recognize only their cognate target mRNAs by
discriminating among the remaining non-cognate ibs
mRNAs, even though the Sib RNAs share extremely
high sequence identity (25). As to the SibA/ibsA pair,
ibsA mRNA appears to be recognized by non-cognate
Sib RNAs (25).
In this study, we sought to identify the essential
elements and sequences of SibC RNA required for the
recognition of ibsC mRNA and then attempted to deter-
mine why SibC RNA is highly selective in its recognition
of ibsC mRNAs. We found two target recognition
domains of SibC, TRD1 and TRD2, which function inde-
pendently. The sequence of TRD1 is suﬃcient to repress
ibsC expression, whereas TRD2 has a speciﬁc structural
requirement. The target recognition sequences of TRD1
and TRD2 are always positioned in highly variable
regions of the ﬁve Sib RNAs. The repression of ibsD by
SibC derivatives containing the TRD1 or TRD2 of SibD
indicates that these elements are used to discriminate
cognate ibs mRNAs from other non-cognate target
RNAs.
MATERIALS AND METHODS
Bacterial strains, plasmids and oligonucleotides
Escherichia coli K-12 strain JM109 was used for the
construction of plasmids and strain MG1655 was
used as the wild-type control. Strains DY330 and
MG1655 were used for the construction of knock-
out strains. Plasmids pBAD/Myc-His B (Invitrogen),
pACYC184, pUC19 and pKK232-8 (Amersham
Pharmacia) were used as cloning vectors. Plasmid pSS6
(36) was used for construction of an IPTG-inducible
RNA expression vector. The oligonucleotides used in
this study are listed in Table 1.
Construction of E. coli strains with mutations in the
ibsC/sibC or ibsD/sibD loci
We performed PCR to construct linear DNA inserts
(i.e. ibsC::kan or ibsD::kan), in which a kanamycin resist-
ant gene was substituted for the ibs ORF and ﬂanked by
the 50 and 30 UTRs of ibs. These inserts were then used
to generate the ibsC/sibC knockout (ibsC/sibC) and
ibsD/sibD knockout (ibsD/sibD) strains from the
wild-type strain MG1655, as previously described
(37,38). Each construct was conﬁrmed by sequence
analysis of the PCR-ampliﬁed knockout regions.
Plasmid construction
Plasmid pAKA, an RNA expression vector and derivative
of pACYC184, was constructed. The tac promoter of
pSS6 was modiﬁed by substituting a lac operator
sequence (50-TCCCTATCAGTGATAGAGA-30) for the
original promoter sequence at two diﬀerent sites (i.e.
immediately upstream of the  35 element as well as
between the  10 and  35 elements) and by inserting the
AatII/HindIII restriction sites immediately downstream of
the  10 element to allow for transcription of a cloned
gene beginning at the same 50 end as that of endogenous
RNA. We then performed PCR with primers tacO-F and
tacO-R to modify the tac promoter. The PCR product was
cloned into the BamHI/HindIII sites of pSS6 to generate
pHM1. The modiﬁed promoter transcription unit,
including the rrnB terminator and the lacI gene of pSS6,
were PCR-ampliﬁed and cloned into the AvaI/EcoRI sites
of the HindIII-inactivated pACYC184 to generate the
pAKA vector. The sibC- and sibD-coding sequences
were ampliﬁed from E. coli MG1655 genomic DNA by
PCR and cloned into the AatII/HindIII sites of the
pAKA vector, thereby generating pAKA-SibC and
pAKA-SibD, respectively. The 50 truncated SibC deriva-
tives were constructed by amplifying the corresponding
SibC coding regions. Substituted derivatives were
generated by introducing mutations into pAKA-SibC
using the Stratagene QuickChange mutagenesis kit.
Chimeric derivatives of SibC/D were constructed accord-
ing to the SOEing PCR method (39). Brieﬂy, the ﬁrst PCR
reactions were performed using primer pairs AatIIC-F/
CD-R and DC-F/Hnd3D-R. The resulting PCR
products were mixed and further ampliﬁed via a second
PCR reaction using the AatIIC-F/Hnd3D-R primer pair
to generate the chimeric 50SibC/30SibD coding sequences.
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Name Sequences (50!30)
a Use
SibCKO1 CCTGATTGACATCGTTGATTCTTTGACCTAATTTAGTGAG
TTATGGACAGCAAGCGAA
DsibC/ibsC strain
SibCKO2 GATTTACGATGGCAGGGCAGCATGGGGCTGTAAGCTCAGA
AGAACTCGTCAAGAAG
DsibC/ibsC strain
SibDKO1 GATTGTGTTGTTACTCGTAAGTTTCGCAGCTATGGACAGC
AAGCGAACCG
DsibD/ibsD strain
SibDKO2 GCCAGGGATATGTGTTAATGAAACCTTCTTTCAGAAGAAC
TCGTCAAGAAG
DsibD/ibsD strain
MscIIC+1 GTTTGGCCATATGGGGATTTACGATGGCAGGG pBAD-ibsC
IC+ERI CCGGAATTCAAGGGTAAGGGAGGATTGCTCC pBAD-ibsC
MscIID+1 GTTTGGCCATAGCGCTCATCAACAATCG pBAD-ibsD
ID+ERI CCGGAATTCACAAGGGTGAGGGAGG pBAD-ibsD
tacO-F CGGATCCATAAATGTGAGCGGATAACATTGACATTGTGAGCGG pAKA
tacO-R CCCAAGCTTGTCGACGACGTCATTATATTGTTATCCGCTCACAATGTC pAKA
AvaIpHM3919 CCCTCGGGCAGATAAAGAAGACAGTC pAKA
AatIIC-F GCGACGTCAAGGGTAAGGGAGGATTG pAKA-SibC
Hnd3C-R CCCAAGCTTGGCTGTAACGGTAAAG pAKA-SibC
AatIID-F GCGACGTCACAAGGGTGAGGGAG pAKA-SibD
Hnd3D-R CCCAAGCTTACGGGAAAGCCCCTCCCGA pAKA-SibD
AatIISC+30 GCGACGTCAGACTGACTGTTAATAAGC pAKA-SibC(30–141)
AatIISC+42 GCGACGTCAATAAGCGCTGAAACTTATG pAKA-SibC(42–141)
AatIISC+46 GCGACGTCAGCGCTGAAACTTATGAG pAKA-SibC(46–141)
pAKA-SibC(46–68)
pAKA-SibC(46–78)
AatIISC+54 GCGACGTCAACTTATGAGTAACAGTAC pAKA-SibC(54–141)
AatIISC+62 GCGACGTCAGTAACAGTACAATCAGTATG pAKA-SibC(62–141)
AatIISC+89 GCGACGTCAGTCGCATCATAACCCTTC pAKA-SibC(89–141)
T51Gf CTGACTGTTAATAAGCGCGGAAACTTATGAGTAACAG pAKA-SibC(U51G)
T51Gr CTGTTACTCATAAGTTTCCGCGCTTATTAACAGTCAG pAKA-SibC(U51G)
C87D-R TGATGAAGCTCGTCATCATACTGATTGTAC pAKA-SibC87D
C87D-F AACAGTACAATCAGTATGATGACGAGCTTC pAKA-SibC87D
D71C-R GATGCGACTTGTCATCATACTGATTGTG pAKA-SibD71C
D71C-F CAACACAATCAGTATGATGACAAGTCGC pAKA-SibD71C
C26D-R TTAACAGCCAATCGGGAGGAGCAATCCTC pAKA-SibC26D
C26D-F GCTCCTCCCGATTGGCTGTTAATAAGCTG pAKA-SibC26D
D27C-R GTCAGTCTCAGAGAGGGGGGAGAAATC pAKA-SibD27C
D27C-F CTCCCCCCTCTCTGAGACTGACTGTTAA pAKA-SibD27C
D94C-R AAGGGTTATGATGAAG pAKA-SibD94C
D94C-F CATCATAACCCTTCTC pAKA-SibD94C
D114C-R GCTTACAGAAGGAAAGGGTTATGATGAAG pAKA-SibD114C
D114C-F CCTTTCCTTCTGTAAGCCCTCGCTTCGGTG pAKA-SibD114C
C48D-R GTTTCGCAGCTTATTAACAGTCAGTCTC pAKA-SibC48D
C48D-F GTTAATAAGCTGCGAAACTTACGAG pAKA-SibC48D
1-78-R CGTTTTATTTCTGATTGTACTGTTACTC pAKA-SibC(1–78)
1-78-F GT ACAATCAGAAATAAAACGAAAGGCTC pAKA-SibC(1–78)
46-68Fu-F CTGAAACTTATGAGTAACAAAATAAAACGAAAGG pAKA-SibC(46–68)
AatII8-77rB GCGACGTCAAGGGTAAAGTATGATGACAAG pAKA-SibC(1–8::77–141)
AatII8-99f GCGACGTCAAGGGTAATAACCCTTCTCC pAKA-SibC(1–8::99–141)
AatII8-90f GCGACGTCAAGGGTAAGTCGCATCATAAC pAKA-SibC(1–8::90–141)
AatII8-77(M) GCGACGTCAAGGGTAAAGTAACTACACAAG
TCGGTAGTTAACCCTTCTCCTTC
pAKA-SibC(1–8::77–141M3)
HndIII8-77 (M) CCAAGCTTGGCTGTAACGGTAAACGCCAGC
CCGAAGACTGGCGTTGAAGGAGAAGG
pAKA-SibC(1–8::77–141M3)
AatII8-29rB GCGACGTCAGGGAGGATTGCTCCTCCCC
TGAAATAAAACGAAAGGC
pAKA-SibC(8–29)
AatII77-99rB GCGACGTCAGTATGATGACAAGTCGCAT
CATAAATAAAACGAAAGGC
pAKA-SibC(77–99)
ERIpHM459 CCGGAATTCCAAAAGAGTTTGTAGAAACGC pAKA
pAKA-SibC(1–78)
pAKA-SibC(46–68)
pAKA-SibC(46–78)
pAKA-SibC(8–29)
pAKA-SibC(77–99)
ERI-T7-ibsC CGGAATTCTTAATACGACTCACTATAGGCAGCATGGGGCTG Template for in vitro
transcription of ibsC
ibsC+159 AAGGGTAAGGGAGGATTGCTCC Template for in vitro
transcription of ibsC
ERI-T7-ibsD CGGAATTCTTAATACGACTCACTATAGGTCAGCAGGGGGCTG Template for in vitro
transcription of ibsD
(continued)
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using the SOEing PCR method, with primer pair
AatIID-F/DC-R and CD-F/Hnd3C-R used for the ﬁrst
reaction and primer pair AatIID-F/Hnd3C-R used for
the second reaction. The chimeric DNA fragments were
cloned into the AatII/HindIII sites of pAKA. We
generated sibC coding sequences containing a 30 deletion
and linked them directly to the rrnB terminator using the
SOEing method. The 30 deleted sibC sequences were cloned
into the AatII/EcoRI sites of pAKA. DNA fragments con-
taining the additional 50 deletion as well as the 30 deletion
were ampliﬁed from the 50 deletion points by PCR using
the corresponding 30 deletion derivatives as templates. If
necessary, the sequences of+1 to+8 were also added to
the 50 deletion derivatives using the SOEing method. The
sequences encoding Sib(1–8::77–141M3), SibC1d, SibC2d
and SibC12d were also PCR-ampliﬁed using the SOEing
method and cloned into the pAKA vector.
The ibsC and ibsD expression plasmids were con-
structed by amplifying nt  21 to +159 of the ibsC
sequence and nt  21 to +165 of the ibsD sequence,
relative to the respective +1 transcription start sites. The
ampliﬁed fragments were then cloned into the MscI/
EcoRI sites of pBK vector, a derivative of pBAD/
Myc-His B (Invitrogen), where an additional MscI site
was introduced to facilitate cloning.
We constructed the ibsC-CAT and ibsD-CAT fusion
plasmids to determine the transcription start sites
of ibsC and ibsD. Promoter-containing DNA fragments,
including the 232 (for ibsC) and 236 (for ibsD) bases
upstream of position  8 relative to the translation initi-
ation codon, were obtained by amplifying genomic DNA
using primer pairs ICBHIibsC(U)/ICHd3ibsC(D) and
ICBHIibsD(U)/ICHd3ibsD(D), respectively. The
resulting PCR products were cloned into the BamHI/
HindIII sites of pKK232-8 to generate the transcriptional
fusion plasmids.
To assess the in vitro transcription of SibC and SibD,
the T7 promoter-containing forward primers and SmaI
site-containing reverse primers were used to amplify the
sibC and sibD structural genes. The ampliﬁed DNA frag-
ments were cloned into pUC19 to generate pUC-SC and
pUC-SD.
Co-transformation assay
Co-transformation eﬃciency was assessed by transform-
ing 25ml of competent cells with 5ng each of an ibs ex-
pression plasmid and a Sib expression plasmid. Cells were
then resuspended in a ﬁnal volume of 300ml of LB media
and placed at 37 C with shaking for 1h. Cells were
incubated on LB plate containing 10mg/ml of tetracycline,
50mg/ml of ampicillin and 1mM of IPTG for 16h at 37 C.
Colony forming ability was then examined.
Preparation of total cellular RNA
Cells were grown overnight in LB broth containing ampi-
cillin (50mg/ml) and if necessary, tetracycline (10mg/ml).
After performing a 1:200 dilution of the overnight culture
in fresh LB, cells were grown at 37 Ct oa nO D 600 of 0.5.
A ﬁnal concentration of 1mM IPTG was added to the cell
culture, followed by another incubation period. Total
cellular RNAs were extracted from the culture as previ-
ously described (37).
Northern blot analysis
In preparation for northern blot analysis, RNA samples
(20mg) isolated from MG1655 cells containing an ibs ex-
pression plasmid and a Sib expression plasmid were
Table 1. Continued
Name Sequences (50!30)
a Use
ibsD+163 AAGGGTGAGGGAGGATTTCTCC Template for in vitro
transcription of ibsD
BHI-SP6-SibC CGGGATCCATTTAGGTGACACTATAGAAGGGTAAGGGAGGATTGC pUC-SC
SibCSmaIERI CGGAATTCCCGGGTAAAGCCCTCACCGAAG pUC-SC
BHI-SP6-SibD CGGGATCCATTTAGGTGACACTATAGACAAGGGTGAGGGAGGAT pUC-SD
SibDSmaIERI CGGAATTCCCGGGAAAGCCCCTCCC pUC-SD
ICBHIibsC(U) CCGGATCCTGCTGTACTAATTCCCCTTC ibsC-CAT fusion plasmid
ICHd3ibsC(D) CCCAAGCTTCTCCTTCAAGCCCTCG ibsC-CAT fusion plasmid
ICBHIibsD(U) CCGGATCCTAAACCCTCTTCCAGG ibsD-CAT fusion plasmid
ICHd3ibsD(D) CCCAAGCTTTCCTTCTGTAAGGCC ibsD-CAT fusion plasmid
C1d-R CATAAGTTTCGCAGCTTATTAACAGTCAG pAKA-SibC1d
C1d-F GTTAATAAGCTGCGAAACTTATGAGTAAC pAKA-SibC1d
C2d-R CTTACAGAAGGAAAGGGTTATGATGC pAKA-SibC2d
C2d-R CCTTTCCTTCTGTAAGCCCTCGC pAKA-SibC2d
5S+90 GAGACCCCACACTACCATCGG Northern
cat1 ACGGTGGTATATCCAGTGAT primer extension
cat2 ATCTCGTCGAAGCTCGGCGG primer extension
C48-50DHr GATGAAGCTCGTCATCATACTGATTGTAC Northern
NPSC+141 GGTAAAGCCCTCACCGAAGCGAGGGCTTG Northern
NPSC46-68 GTTACTCATAAGTTTCAGCGCT Northern
NPSC77-99 ATGATGCGACTTGTCATCATACT Northern
NPSC8-29 CAGGGGAGGAGCAATCCTCCCT Northern
aRestriction sites are underlined.
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7M urea and electrotransferred to a Hybond N+
membrane (Amersham Biosciences). The membranes
were then hybridized with oligonucleotide probe
C48-50DHr for SibC, chimeric SibC/D, and SibD. The
C48-50DHr could hybridize with both SibC and SibD.
The 50-deleted SibC derivatives were probed with
NPSC+141. The 30-deleted SibC derivatives were probed
with the corresponding Sib-antisense oligonucleotides
(NPSC46-78, NPSC77-99 and NPSC8-29). 5S RNA was
probed with oligonucleotide 5S+90. Oligonucleotides were
labeled at the 50 end with [g-
32P] ATP and T4 polynucleo-
tide kinase (Takara) and used for hybridization.
Primer extension analysis
Two primers cat1 (50-ACGGTGGTATATCCAGTGAT)
and cat2 (50-ATCTCGTCGAAGCTCGGCGG) were
labeled with [g-
32P] ATP at the 50 end using T4 poly-
nucleotide kinase. The pimers were then used to analyze
ibsC-CAT and ibsD-CAT fusion transcripts. Total cellular
RNA was isolated from cells carrying the ibsC-CAT or
ibsD-CAT fusion plasmid. The two diﬀerent primers
were separately used for primer extension analysis, as pre-
viously described (37).
In vitro transcription
SibC and SibD RNAs were prepared by in vitro transcrip-
tion using SP6 RNA polymerase (Promega), with
SmaI-digested pUC-SC and pUC-SD as templates. ibsC
and ibsD mRNA transcripts were generated using T7
polymerase and PCR products that had been ampliﬁed
using primer pair ERI-T7-ibsC/ibsC+159 and ERI-T7-
ibsD/ibsD+163, respectively. The transcripts each con-
tained an extra G sequence at their 50 end because of the
SP6 or T7 promoter sequence.
In vitro RNA-binding assay
In preparation for binding assays, 50 end-labeled SibC
or ibsC RNA (10nM) was incubated with unlabeled
ibsC or SibC (10, 25or 100nM) in 10ml TMN buﬀer
[100mM Tris–acetate, pH 7.6, 500mM NaOAc,
25mMMg(OAc)2]a t3 7  C for 15min. The reaction was
stopped by dilution with an equal volume of
non-denaturing loading buﬀer (0.025% xylene cyanol,
2% glycerol, 1  TBE). The reactions were then analyzed
on 5% (v/v) polyacrylamide gels.
Chemical and enzymatic structure probing
SibC and ibsC mRNAs were 50 end-labeled with [g-
32P]
ATP using T4 polynucleotide kinase (Takara). The labeled
RNA molecules were renatured by heating for 1min at
95 C, chilling on ice for 3min and slowly returning to
room temperature. The 50-end-labeled RNAs were
pre-incubated with 1mg yeast tRNA in 5 TMN buﬀer
for 15min at 37 C. Unlabeled ibsC mRNA or SibC
RNA was then added to the reaction, yielding a total
reaction volume of 10ml. The reactions were then
incubated at 37 C for 15min. Subsequently, 1mlo f
RNase V1 (0.01U, Ambion), RNase T1 (0.75 U,
Ambion), Pb(II) (25mM, Sigma Aldrich) or RNase III
(1 U, New England Biolabs) was added and the reactions
was incubated at room temperature for various time inter-
vals. The RNase III reaction was performed in additional
1mM DTT. The reaction was stopped by adding 2mlo f
0.5M EDTA. The RNAs were precipitated and resus-
pended in 10ml gel loading buﬀer II (Ambion). Samples
were denatured at 95 C for 3min and immediately loaded
on a 5% (v/v) polyacrylamide-9M urea sequencing gel.
RNase T1 ladders and OH ladders were obtained accord-
ing to the Ambion manufacturers’ speciﬁcations.
The binding rate assay to evaluate RNase-cleavage pro-
tection was performed as previously described (40).
Brieﬂy, 50 end-labeled ibsC mRNA (10nM) was incubated
with unlabeled SibC (50nM) in a total reaction volume of
10ml in TMN buﬀer at 37 C for several time points.
Samples were immediately cleaved by RNase V1 (0.01U)
for 15min and the cleavage reaction was stopped by
ethanol precipitation. The products were analyzed on a
5% polyacrylamide gel as described above.
RESULTS
Co-transformation assays for the evaluation of ibs
repression by Sib RNA derivatives
We evaluated the ability of Sib RNA derivatives to repress
ibs expression by taking advantage of the fact that Ibs
toxicity is repressed by the overexpression of Sib RNA
(25). We expressed ibs and Sib RNA from an
arabinose-controlled promoter and an IPTG-controlled
promoter, respectively, harbored on the plasmid in vivo.
Wild-type MG1655 cells were transformed with an ibsC
expression plasmid and the transformed cells grew in the
absence of arabinose. However, the ibsC/sibC strain
could not be transformed with the ibsC expression
plasmid, indicating that the basal level of ibs expressed
by the plasmid is suﬃcient to induce cell toxicity in the
absence of SibC expression and that this cell toxicity can
be repressed by endogenously expressed SibC. Indeed, the
ibsC expression plasmid could be introduced into the
knockout cells by co-transformation with the
IPTG-induced SibC expression plasmid (Figure 1).
Co-transformants were not generated with a SibD RNA
expression plasmid, suggesting that IbsC toxicity is re-
pressed by cognate SibC RNA, rather than by
non-cognate SibD, consistent with previous reports (25).
Thus, we performed co-transformation assays to evaluate
ibsC repression by SibC RNA derivatives. The
colony-forming ability of ibsC/sibC cells was assessed
with co-transformation eﬃciency in the presence of
1mM IPTG after cells were transformed with both the
RNA and ibsC expression plasmids. We also performed
northern blot analyses to conﬁrm the overexpression
of Sib RNA derivatives. We found that all derivatives
are expressed at higher levels than endogenous SibC
(Figure 2).
50 Deletion analysis of SibC RNA
To identify the sequences of SibC RNA that aﬀect ibsC
repression, we constructed plasmids expressing SibC
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end (Figure 1A). These truncated derivatives were used
in co-transformation assays. A 29-nt deletion on the 50
end [i.e. SibC(30–141)] did not alter colony-forming
ability of ibsC/sibC strains, compared with the
wild-type strain. However, further deletion to +61 [i.e.
SibC(62–141)] and +89 [i.e. SibC(90–141)] eliminated
colony formation. These results indicate that nt +1 to
+29 of SibC RNA are not required for ibsC mRNA
recognition, while the nucleotides between +30 and +61
are essential for ibsC mRNA recognition. To further de-
lineate the sequences that are essential for ibsC repression,
we constructed three additional deletion derivatives,
SibC(42–141), SibC(46–141) and SibC(54–141) (Figure
1A). SibC(42–141) and SibC(46–141) yielded colonies,
but SibC(54–141) did not. Hence, we narrowed the essen-
tial region to the nucleotides between +46 and+53 of
SibC. It is noteworthy that SibC(46–141) yielded smaller
Figure 1. Co-transformation assays were performed using various derivatives of SibC. The schematically drawn sequences were cloned into pAKA
to generate, SibC, SibC derivatives and SibD in vivo. Co-transformation eﬃciency was assessed in cells co-transformed with 5ng each of an ibs
expression plasmid and a Sib RNA expression plasmid by counting the number of transformants. The data are representative of at least three
separate experiments. The error was <20%. (A) SibC derivatives truncated at the 50 end. (B) SibC/D chimeric derivatives. (C)3 0 Deletion derivatives
and minimal motif-carrying derivatives. ‘S’ in parentheses indicates formation of small colonies. Stem-loop regions shown in Figure 3 are indicatedi n
the schematic structure of SibC and SibD.
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gesting that SibC(46–141) is a less eﬃcient repressor. In a
secondary structure model of SibC, the sequence between
+46 and +53 lies on the P5 loop (Figure 3). However, a
U-to-G modiﬁcation in this loop [i.e. SibC(U51G)] did not
aﬀect colony formation (Figure 1A).
SibC/D chimeras
It is possible that the 50 truncated SibC derivatives were
non-functional because the RNA structure was signiﬁcant-
ly altered by the deletion. Another possibility is that there
are multiple recognition sites, which function independent-
ly. Because SibD did not repress ibsC expression in the
co-transformation assays, even though they share 82%
sequence similarity and have a conserved secondary struc-
ture, we constructed SibC/SibD chimeric derivatives in
which the 50 or 30 regions of SibC were replaced with the
corresponding regions of SibD (Figure 1B). First, we
examined 50-SibC/30-SibD chimeras (e.g. SibC26D and
SibC48D) and the SibC87D construct where the numbers
indicate the 30 fusion points of SibC. The SibC26D and
SibC48D constructs did not repress ibsC expression,
whereas SibC87D did. These data indicate that the+1 to
+48 sequence of SibC is not involved in target recognition
and that the+49 to+87 sequences is suﬃcient for recog-
nition. This result is consistent with our 50 deletion analysis
showing that the sequence between +46 and +53 is
essential for target recognition. We then examined
50-SibD/30-SibC chimeras (i.e. SibD27C, SibD71C,
SibD94C and SibD114C, where numbers indicate the 50
fusion points of SibC). As expected, SibD27C repressed
ibsC expression. Surprisingly, SibD71C and SibD94C
also showed ibsC repression, although their colony sizes
were small. This conﬂicts with the result of our 50
deletion analysis, which showed that 50 53-nt deletion
mutants lost the ability to repress transcription. The
SibD-extended version of SibD114C did not exhibit ibsC
repression. Therefore, it is likely that the +95 to +113
sequence of SibC is included in another independent
element capable of repressing ibsC expression.
More deletion analyses
We performed further deletion analyses, including 30 dele-
tions (Figure 1C). Because the 30 deletion could disrupt or
remove the sibC termination hairpin, constructs were
designed so that the deletion points were fused to the
rrnB terminator hairpin and transcription would termin-
ate at the terminator. As expected from our observations
of SibC/D chimeric derivatives, ibsC expression was re-
pressed by SibC(1–78), which harbored a deletion from
the 30 end to nucleotide+79. Further deletion derivatives
SibC(46–78) and SibC(46–68) also repressed ibsC expres-
sion, although they yielded small colonies. Therefore, the
23nt between +46 and +68 are suﬃcient for ibsC
Figure 2. Expression of Sib derivatives. MG1655 cells containing the pAKA-Sib plasmids, as shown in Figure 1, were treated with IPTG (ﬁnal
concentration of 1mM). Total cellular RNAs were prepared from these cells and subjected to northern blot analysis. (A) SibC derivatives truncated
at the 50 end were probed with NPSC+141. (B) SibC/D chimeric derivatives were probed with C48–50DHr. (C)3 0 Deletion derivatives and minimal
motif-carrying derivatives were probed with NPSC46-68 (lanes 1–4), NPSC77-99 (lanes 5–7) and NPSC8-29 (lanes 8–10). Vec., vector DNA.
Plasmid-borne Sib derivatives and endogenous Sib RNA species are marked with asterisks and daggers, respectively. When Sib RNAs were
highly expressed, their truncated species lacking about 30nt at the 30 end were also observed.
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essential recognition sequence of +46 to +53, which was
demonstrated by 50 deletion analysis. SibC(8–29) and
SibC(77–99), which contained loops P2 and P6, respect-
ively, did not exhibit ibsC repression, indicating that the
loop sequence of P5 speciﬁcally promotes ibsC repression
(Figure 3).
We then sought to determine why a construct harboring
a 61-nucleotide deletion on the 50 end lost the ability to
repress ibsC, while the replacement of 93nt at the 50 end of
SibC with the corresponding SibD sequence in a SibC/D
chimeric construct did not alter repression. The replaced
SibD sequence in SibC/D chimeric constructs might
provide structural platforms that are essential for the
function of the remaining SibC sequence. As nt +95
to +113 of SibC are involved in ibsC repression
(Figure 1B), we focused on an RNA structure that
includes this sequence. Because this structure may
contain the P1 stem, we added nt +1 to +8 to the
ineﬀective 50 deletion derivatives to create the P1 stem.
SibC(1–8::77–141) repressed ibsC (Figure 1C), indicating
that the P1 stem generated by the addition of the+1 to+8
sequence is required for repression by the +77 to +141
sequence. The SibC(1–8::99–141) construct, which lacked
the P6 stem and loop, did not repress ibsC (Figures 1C
and 3). To determine if the lack of repression by
SibC(1–8::99–141) was due to a sequence or structure re-
quirement, we generated a SibC(1–8::90–141) construct
that included more sequence but lacked the P6 structure.
SibC(1–8::90–141) repressed ibsC, albeit yielding small
colonies (Figure 1C), suggesting that the P6 structure is
not crucial but the +90 to +98nt are required for ibsC
repression. Further mutational analysis was performed
to deﬁne the minimal sequence required for complemen-
tary base-pairing in the P1-containing structure. We
introduced mutations into stems P6 and P7 of
SibC(1–8::77–141) by exchanging the complementary
stem sequences so that the mutant constructs would
Figure 3. Possible secondary structures of SibC (A) and its derivatives (B). The structures were predicted using the CLC workbench program,
version 4.2. The stem regions of SibC are assigned as P1 through P7. The single-stranded regions connected between two stems are denoted by
J(preceding stem number)/(next stem number); e.g. J1/2 is the junction region between stems 1 and 2.
5858 Nucleic Acids Research, 2010, Vol.38, No. 17retain the same secondary structure (Figure 3B).
SibC(1–8::77–141M3), which contained the 17nt from
+99 to +115, repressed ibsC (Figure 1C), indicating that
this contiguous sequence is suﬃcient for the speciﬁc rec-
ognition of ibsC mRNA. However, this result is inconsist-
ent with our ﬁnding that SibC(1–8::99–141), which carries
this 17-nt sequence, was incapable of repression. The
reasons for this discrepancy remain unclear, although it
is likely that the 17-nt sequence may require an additional
sequence element, such as the P6 loop in
SibC(1–8::77–141M3), the +90 to +98 sequence in
SibC(1–8::90–141), the+94 to+98 sequence in SibD94C.
Together, our data indicate that SibC RNA possesses
at least two target recognition domains that function
independently. These domains are encoded by nt +46
to +68 and by nt +99 to +115, which we have named
target recognition domains 1 and 2 (TRD1 and TRD2),
respectively. TRD1 consists of the P5 loop, whereas
TRD2 contains J1/7 and is active only when bound to
a speciﬁc structure that contains at least the P1 stem
(Figure 3).
Interactions between SibC and ibsC mRNA
To analyze the interactions between SibC and ibsC
mRNA, we performed structure-probing experiments.
The 50 and 30 ends of Sib RNAs were well deﬁned, but
those of the ibs mRNAs were not. Previous northern-blot
analysis showed that the ibsC mRNA was approximately
160-nt long (25); thus, we attempted to determine the 50
ends of the ibsC and ibsD mRNAs by primer extension
analysis and to predict the location of the 30 end by
measuring its distance from the 50 end. The putative
promoter regions were cloned into pKK232-8, a
promoterless CAT expression vector, and the 50 ends of
the ibs-CAT transcriptional fusion mRNA were
determined (Figure 4A). The upstream regions of the
ibsC and ibsD genes contained conserved promoter
elements and the 50 ends corresponded with the putative
transcription initiation sites (Figure 4B). From these data,
we synthesized ibsC and ibsD mRNAs of 159 and 163nt,
respectively, by in vitro transcription.
Electrophoretic mobility shift assays showed that SibC
speciﬁcally binds to ibsC mRNA to form a SibC–ibsC
complex at 37 C, whereas non-cognate SibD failed to rec-
ognize ibsC mRNA (Figure 5). When SibD and ibsC
mRNA were denatured at 95 C and then annealed, the
SibD–ibsC complex formed (Figure 5, lane 9). This
result indicates that SibD can recognize ibsC mRNA via
base-pairing through the denaturation and annealing
process, but not naturally.
Figure 4. Identiﬁcation of the ibsC and ibsD transcriptional start sites.
Total cellular RNAs were prepared from cells containing the ibsC-CAT
or ibsD-CAT fusion plasmid, then subjected to primer extension
analysis. (A) Extension products from two diﬀerent primers cat1 (left)
and cat2 (right) were electrophoresed on a 5% polyacrylamide
sequencing gel containing 7M urea. The DNA sequencing ladders
were prepared using the same primers and ibsC-CAT or ibsD-CAT
fusion plasmid DNA as the template. (B) Promoter elements are
shown in the ibsC or ibsD sequence. Transcription start sites
determined by primer extensions analysis are indicated by arrows.
The 50 and 30 ends of in vitro-transcribed ibsC and ibsD RNA used
for the in vitro binding assay and structural mapping in this study are
indicated by the arrows below the sequences.
Figure 5. Binding assay of SibC RNA with ibsC mRNA. (A)
32P-labeled SibC RNA (10nM) was incubated at 37 C for 15min
with increasing amounts of unlabeled ibsC mRNA or ibsD mRNA
(10nM to 100nM). The binding mixtures were divided; one group of
samples (lanes 1–7) was loaded directly on the 5% native gel, whereas
the other group of samples (lanes 8 and 9) was heated 95 C for 3min
and slowly cooled to room temperature prior to loading on the
5% native gel. (B) Reciprocal interactions between the
32P-labeled
ibsC mRNA and the unlabeled SibC RNA were assessed as described
in (A).
Nucleic Acids Research, 2010, Vol.38, No. 17 5859The interactions between SibC and ibsC were analyzed
by RNA structure mapping. The 50 end-labeled SibC
RNA was probed with RNase T1, lead(II), RNase V1
and RNase III in the presence of increasing amounts of
ibsC mRNA (Figure 6 and Supplementary Figures
S1–S4). The eﬀects of ibsC mRNA on each cleavage
pattern were observed over most of the SibC sequence,
indicating extensive base-pairing of the SibC–ibsC
mRNA complex. However, this RNA–RNA complex
appears to not form a complete duplex because the
cleavage patterns diﬀered from those of a SibC–ibsC
duplex generated by denaturation and annealing. In the
presence of ibsC mRNA, fewer RNase T1 cleavages were
observed within the region spanning G18 to G90.
Prominent reductions of RNase T1 cleavages were
observed at G47 and G49 within the P5 stem and loop
(Figure 6A, lanes 6 and 7; Figure 6C). Binding of ibsC
mRNA extensively reduced lead(II) cleavages of SibC
RNA (Figure 6D). The reduced regions were extended
from G29 to C116. Fewer lead(II) cleavages were
observed in the region spanning C106 to C116; however,
RNase T1 cleavages were not altered because this region
contains no G nucleotides (Figure 6A, lanes 10 and 11;
Figure 6C). Two regions were predominantly protected:
the G48 to G50 residues of stem P5 and the C107 to C113
residues of J1/7. Interestingly, A54 became more suscep-
tible to lead(II) cleavage upon binding to ibsC mRNA,
suggesting a marked structural rearrangement of the P5
loop after binding. RNase V1 cleavage patterns revealed
an increase in cleavage in three loop regions of stems P2,
P5 and P6. Therefore, these three regions are likely to
interact with ibsC mRNA. TRD1 and TRD2 are located
in P5 and J1/7; hence, the interaction of stems P2 and P6
with ibsC mRNA should be non-productive. RNase
V1-sensitive sites near the J7/1 region became resistant
to the enzyme and this resistance was also found in the
complete duplex (Figure 6A, lanes 3 and 4; Figure 6B).
These ﬁndings indicate that interactions in this region
promote a marked structural change that might result in
longer duplex formation. RNase III, a
double-strand-speciﬁc nuclease that cleaves full duplexes
of about 20 or more base-pairs (41), almost completely
digested the fully base-paired SibC–ibsC mRNA duplex
by generating only short fragments, while the enzyme par-
tially digested the SibC–ibsC mRNA complex with
generating more cleavage products (Figure 6A, lane 15
and 16). These results suggest that the SibC–ibsC
mRNA complex with unpaired regions is a poorer sub-
strate for RNase III than the complete duplex. The RNase
III treatment of the complete duplex generated fragments
of 9–21 and 21–34nt from the labeled 50 ends of SibC and
ibsC mRNA, respectively (Figures 6 and 7). These cleav-
ages are quite consistent with the observation that the
cleavage site of RNase III is 10–14bp away from 30 ends
of RNA duplex (42), considering that the complete SibC–
ibsC mRNA duplex has a 50 overhang of 18nt in the ibsC
mRNA sequence and that the RNase III cleavage of this
duplex could result in that much longer fragments from
the labeled 50 ends of ibsC mRNA (Figure 7) than SibC in
the duplex (Figure 6). As for the SibC–ibsC mRNA
complex, RNase III-cleavage patterns markedly changed
as the concentration of target RNA increased, suggesting
that interactions between SibC and ibsC promote overall
structural changes in RNA.
We performed a reciprocal probing experiment using
50-labeled ibsC mRNA (Figure 7 and Supplementary
Figures S5–S8). The addition of SibC changed the
cleavage patterns of several regions within ibsC mRNA.
The eﬀects of SibC RNA were observed throughout the
ibsC mRNA sequence. RNaseT1 and lead(II) probing
data showed that cleavages were reduced over most of
the ibsC mRNA sequence. RNase T1 cleavages at G50,
G51 and G53 of J2/3 were completely blocked, likely due
to base-pairing with C107, C109 and C110 of TRD2 of
SibC. However, this region in the absence of SibC was
cleaved by lead(II) but not by RNase V1, indicating that
this region forms a special structure that undergoes
dynamic changes in response to interactions with SibC.
The three loop regions (i.e. loops P2, P4 and P7) became
sensitive to RNaseV1 cleavage (Figure 7A, lanes 2 and 3:
Figure 7B). The P7 loop of ibsC mRNA is complementary
to the P5 loop of SibC, which includes the TRD1. The P7
loop contains a YUNR motif, which was previously
reported to be involved in the initial RNA–RNA recogni-
tion (43). This YUNR motif might also play a crucial role
for the initial contact between ibsC and SibC. The ibsC
mRNA exhibited distinct RNase III-cleavage patterns in
response to SibC binding, similar to the SibC probing
data.
Our structure probing data showed that SibC–ibsC
mRNA interaction occurred at multiple sites. We per-
formed a time-course experiment to determine whether
TRD1 and TRD2 are the initial interaction sites from
which RNA–RNA base-pairing commences. The 50
end-labeled ibsC was probed with RNase V1 at various
time points during incubation with unlabeled SibC
(Figure 8 and Supplementary Figure S9). Cleavages at
the P7 stem-loop region that could be recognized by
TRD1 gradually increased with the reaction time.
RNase V1-resistance of the J2/3 region, which is comple-
mentary to TRD2, was not observed in the presence of
SibC because this region was already resistant to RNase
V1 without SibC; however, cleavage decreased in the
ﬂanking stems (i.e. P2 and P3), suggesting that the stems
are rearranged to form a longer duplex. In contrast, cleav-
ages at residues A69 and U72 of the P4 loop were visible
immediately but further changes were not observed over
time. This may explain why interactions between the P6
loop of SibC and the complementary P4 loop of ibsC were
non-productive in our co-transformation assays. These
results indicate that two independent recognition
elements (i.e. TRD1 and TRD2) are initial contact sites
that allow base-pairing to proceed into nearby sequences,
thereby promoting longer RNA–RNA duplex formation.
When the interaction is followed by pseudo-ﬁrst-order
kinetics, densitometric analysis of cleavage bands in the
P7 loop and P2 stem of ibsC yields binding rate constants
of  5 10
5 and  2 10
5M
 1s
 1, respectively. These
values are similar to previously reported information
about the stable antisense/sense RNA complex
( 10
6M
 1s
 1) (21).
5860 Nucleic Acids Research, 2010, Vol.38, No. 17Figure 6. Interaction of SibC with ibsC mRNA. (A)
32P-labeled SibC RNA (10nM) was partially digested with RNase V1, RNase T1, lead(II) and
RNase III in the absence (lanes 1, 5, 9 and 13) and presence of increasing amounts of unlabeled ibsC mRNA (25nM ﬁnal concentration: lanes 2, 6,
10 and 14; 100nM ﬁnal concentration: lanes 3, 7, 11 and 15). The fully paired SibC–ibsC mRNA complex was generated by heating and annealing
with 100nM ibsC. The complex was then used for digestion (lanes 4, 8, 12 and 16). Untreated SibC and alkaline ladders are shown in lanes C and
OH, respectively. Lane T1 corresponds to the RNase T1 ladders of denatured SibC RNA. The positions of the cleaved G residues are shown on the
left side of the gel. The altered sites of RNase V1 (B), RNase T1 (C), lead(II) (D) and RNase III (E) cleavage/protection in the presence of ibsC
mRNA are shown in the secondary structure of SibC. The complementary sequences corresponding to the S/D region, start codon and stop codon of
ibsC mRNA are indicated by boxes. Increasing and decreasing cleavages are indicated by solid and open symbols, respectively.
Nucleic Acids Research, 2010, Vol.38, No. 17 5861Figure 7. Interaction of ibsC mRNA with SibC. (A) A reciprocal enzymatic and chemical footprint experiment was performed by labeling the 50 end
of ibsC mRNA, as described in Figure 6. The RNase V1 (B), RNase T1 (C), lead(II) (D) and RNase III (E) protected or cleaved residues are shown
in the secondary structure model of ibsC. The S/D sequence, start codon and stop codon are indicated by boxes. Increasing and decreasing cleavages
are indicated by solid and open symbols, respectively.
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We have identiﬁed two target recognition domains of
SibC: TRD1 and TRD2. Because Sib RNAs do not
cross-react with non-cognate ibs mRNAs with the excep-
tion of the ibsA/SibA pair, we tested whether these two
elements inﬂuence target speciﬁcity. We compared the se-
quences of ﬁve pairs of Sib RNA species. The TRD1 and
TRD2 domains are positioned within highly variable
regions of the ﬁve Sib RNAs. Furthermore, our results
showed that these two elements exhibit high sequence vari-
ation and can severely disrupt the contiguity of a sequence
when the Sib RNAs occur in any combination of pairs
(Supplementary Figure S10), suggesting that these
elements play a role in target discrimination. Thus, we
replaced one or both of the elements in SibC with those
of SibD. The changes from G49CU51 to UGC and from
C107UCCUUC113 to UCCUUCUGU allowed SibC to
base-pair with ibsD through mutated TRD1 and TRD2
elements, respectively. Mutated TRD1 and TRD2
elements can form contiguous 22 and 25-bp helices, re-
spectively, with ibsD mRNA. A change in either one of
the two TRD elements of SibC represses ibsC (Figure 9).
However, a change in both elements eliminated the repres-
sive activity of SibC, even though the mutant SibC still
contained approximately 100nt that were complementary
to the ibsC mRNA. These data provide further evidence
Figure 8. Time course of the interactions between SibC and ibsC RNA. (A)
32P-labeled ibsC RNA (10nM) was incubated with 50nM of unlabeled
SibC RNA at 37 C for 1, 30, 90 and 360s. Samples were withdrawn from each time point and digested with RNase V1 for 15min. The reaction was
stopped by ethanol precipitation. Lanes C and OH correspond to untreated ibsC RNA and alkaline hydrolysis ladders, respectively. Lane T1
corresponds to G ladders generated by RNase T1 under denaturing conditions. The regions showing signiﬁcant changes in the intensities of bands are
denoted as a to e.( B) The regions showing signiﬁcant changes during the time course of incubation are also shown in the secondary structure model
of ibsC mRNA.
Nucleic Acids Research, 2010, Vol.38, No. 17 5863that SibC has two elements for ibsC recognition and that
these elements function independently. The Sib derivatives
containing either one of the two elements were able to
repress ibsD (Figure 9), suggesting that through these
elements Sib RNAs can discriminate cognate ibs
mRNAs from non-cognate target RNAs.
DISCUSSION
In this study, we identiﬁed the essential elements and se-
quences of SibC RNA that are required for the recogni-
tion of target ibsC mRNA. SibC RNA has two target
recognition domains, TRD1 and TRD2. Either of these
domains can repress ibsC expression; therefore, the
domains function independently. The target recognition
domains TRD1 and TRD2 span the regions of +46 to
+68 containing the P5 loop and +99 to +115 including
the J1/7 single-stranded region, respectively. TRD1 is
suﬃcient to repress ibsC expression. However, TRD2
appears to require the formation of the P1 stem because
TRD2 is functional only in the presence of the sequence of
+1 to +8 that could form the P1 stem with the +101 to
+106 sequence of TRD2. Since the TRD2 sequence is
followed by the P7 transcription terminator stem, the
+107 to +114 sequence becomes positioned in the J1/7
region. This positioning of TRD2 in the SibC sequence
might be needed to maintain its recognition sequence as
a single-stranded segment. In addition to this
single-strandedness, TRD2 seems to require another inter-
action through the P6 loop, because SibC(1–8::99–141), a
derivative consisting of the P1 stem and loop, J1/7, and
the P7 stem-loop, cannot repress ibsC expression unless it
holds an additional GUCG sequence of the P6 loop as in
the active SibC(1–8::90–141) and SibC(1–8::77–141M3)
derivatives. It is noteworthy; however, that the spatial lo-
cations of SibC target sites within ibsC mRNA may be
important for the SibC–ibsC mRNA interaction. In case
of truncated SibC derivatives, their RNA structures might
diﬀer from that of the intact SibC and there is a possibility
for generating a new target recognition domain in the
truncated derivatives. Nonetheless, they recognized ibsC
mRNA only when TRD1 existed. Therefore, the target
sequence of TRD1 within ibsC mRNA could be located
in an accessible region. The result that this target sequence
in the P7 stem-loop of ibsC mRNA is hypersensitive to
lead(II) (Figure 7) supports this possibility.
Our in vitro probing analysis revealed that initial inter-
actions by TRD1 and TRD2 promote further base-pairing
into the ﬂanking sequences. Therefore, these initial
contacts serve as productive target recognition signals.
The ﬁnal SibC–ibsC mRNA complex formed by progres-
sive base-pairings does not seem to be a fully paired
duplex because the mapping patterns for enzymes and
lead(II) diﬀered from those of the RNA duplex formed
through the denaturation and annealing process, suggest-
ing that the partial base-pairing, but not complete duplex
formation, occurs in vivo and that the limited number of
base-pairing of SibC with ibsC mRNA is enough for the
ibsC repression. The suﬃciency of the partial base-pairing
for the action of cis-encoded sRNA was also previously
observed (21). However, the partial base-pairing should be
a productive one, just as that through TRD1 or TRD2 of
SibC for recognizing ibsC mRNA in this study. The
binding rate constants of each TRD domain of SibC for
the partial base-pairing were comparable to previously
known stable antisense/sense RNA complex, suggesting
Figure 9. Co-transformation assays with SibC derivatives harboring mutations at the TRDs. (A) Co-transformation eﬃciency was assessed in cells
transformed with both an ibs expression plasmid and an Sib RNA expression plasmid, as described in Figure 1. The TRD1 and TRD2 domains of
SibC1d and SibC2d were substituted with those of SibD, respectively. SibC12d possesses the TRD1 and TRD2 domains of SibD. (B) To assess the
expression of SibC derivatives, MG1655 cells containing pAKA-Sib plasmids were treated with IPTG (ﬁnal concentrations of 1mM). Total cellular
RNAs were prepared from these cells and subjected to northern blot analysis.
5864 Nucleic Acids Research, 2010, Vol.38, No. 17SibC–ibsC interaction occur as rapidly as other antisense–
sense interactions (21).
Repression of ibsC by SibC results in the degradation of
ibsC mRNA (25). The target site of TRD1 is located
within the ORF of ibsC, whereas that of TRD2 is in
the TIR. The function of TRD1 may be similar to the
down-regulation of ompD by MicC whose binding to the
target sequence within ompD ORF can promote mRNA
degradation without inhibition of translation initiation in
Salmonella typhimurium (44). The two independent TRDs
could be used to assure full repression of ibsC expression
until it is needed by the cells. This tight regulation may be
essential to protect cells from the highly deleterious eﬀect
of the IbsC toxin protein.
There are ﬁve ibs/Sib genes. Each Sib RNA recognizes a
distinct cognate ibsC mRNA, despite the fact that Sib
RNAs and ibs mRNAs are highly homologous each
other. Therefore, the TRD1 and TRD2 domains should
be involved in the discrimination of non-cognate ibs
mRNAs. It is noteworthy that TRD1 and TRD2 are
located in highly variable regions in members of the Sib
RNA family (Supplementary Figure S10). Even when two
Sib RNAs are compared, these regions are always
variable. This high sequence variability is required for
the discrimination of non-cognate ibs mRNA by Sib
RNA. Indeed, we found that the SibC mutants, whose
TRD1 or TRD2 sequences were mutated to match those
of SibD, repressed ibsD expression. Therefore, it is
possible that the Ibs/Sib toxin/antitoxin system was
duplicated and evolved to discriminate by assigning
TRD1 and TRD2 to variable regions. It has been
reported that SibA-deﬁcient cells are viable although
these cells express ibsA, which contrast with other Sib
RNA-deﬁcient cells that become lethal if cognate ibs
mRNAs are expressed (25). Our co-transformation
assays also showed that expression of ibsA in ibsA/
sibA cells had no eﬀect on cell survival (K.Han, unpub-
lished results). These results suggest that other Sib RNA
than SibA can recognize ibsA mRNA. Interestingly, the
corresponding regions to the+90 to+113 of SibC region
are the same between SibA and SibE. This region contains
not only the TRD2 sequence but also the GCUU sequence
(corresponding to GUCG of SibC) of the P6 loop.
Therefore, one may argue that SibE could cross-recognize
ibsA mRNA. However, it remains to be further
demonstrated because SibA cannot repress ibsE (25).
It remains unclear why expression of the Ibs toxin
family is regulated only by their own cognate SibC
RNAs. It is possible that expression of each ibs gene is
diﬀerentially regulated so that distinct Ibs proteins are
synthesized under diﬀerent conditions. The upstream
regions of the ibsC and ibsD promoters have putative
binding sites for diﬀerent transcription factors (unpub-
lished results). Alternatively, as the sequences of ﬁve Ibs
toxin proteins are homologous but not identical, these
proteins may have their own speciﬁc functions. Similar
hydrophobic toxin peptides such as ShoB are believed to
play diﬀerent functions compared with SibC (25). If this is
the case, expression of each Ibs protein may need to be
regulated separately.
Cis-encoded sRNA may diﬀer from trans-encoded
sRNA because it has the potential to form a relatively
long contiguous duplex with its target RNA. Although
the Sib/ibs pair is operated in cis in the cell, we assessed
the ability of SibC derivatives to repress ibsC expression in
trans by expressing SibC and ibsC mRNA on two diﬀerent
plasmids. This trans operation might require much more
Sib RNA than the naturally occurring cis operations, and
cis-regulation could be more eﬀective than trans-regula-
tion owing to the greater local concentrations of interact-
ing RNA molecules. Nonetheless, our ﬁndings show that
ibsD expression can be repressed by a SibC mutant that is
capable of forming a contiguous 22-nt duplex speciﬁc to
ibsD. Therefore, it seems likely that the mechanism of cis-
encoded sRNA does not signiﬁcantly diﬀer from that of
trans-encoded sRNA.
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